Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Lauren Nardella
Cross Brands Manufacturing’s stingily hand-picked in vitro test results for Sea & Ski sunscreens do not demonstrate a clear, consumer-relevant infrared protection capability, let alone show that IR defense translates to meaningful skin-health benefits, according to the National Advertising Division’s Sept. 7 decision.
The Cosmetic Ingredient Review’s draft report on brown algae-derived ingredients is up for Expert Panel consideration Sept. 24-25, and five Ginkgo biloba ingredients could receive final safe-as-used sign-off. CIR also seeks the panel’s help in preparing a re-review document for the MI/MCI preservative combination, which is overdue for an updated assessment with usage up significantly since 1992.
While overshadowed by contentious cosmetic animal-testing legislation, AB 2775 also passed in the closing days of California’s 2017-2018 legislative session, another example of the state’s eagerness to take on cosmetics issues it views as inadequately addressed at the federal level.
Late-stage, industry-driven amendments to SB 1249 eliminated terms that could have made companies liable for animal testing entirely outside their control. The bill that passed Aug. 31 is still rife with legal risks for companies that claim exemptions, according to Sacramento-area attorney Angela Diesch.
Coty’s ongoing integration of P&G beauty assets, going on two years after the deal’s completion, has compounded challenges for its Consumer business, which faces a very different market today compared with conditions when Coty outbid rivals for CoverGirl, Max Factor and other P&G castoffs.
The ingredients at issue already must be labeled on cosmetic products in the EU due to their recognized sensitization and allergy potential. FDA expects to award the contract by the end of September, and finished work will be due to the agency within 18 months thereafter.